Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model

Cryobiology

Volumn 59, Issue 2, 2009, Pages 207-213

  Ismail, Mohamed ^a,b   Morgan, Richard ^a   Harrington, Kevin ^c   Davies, John ^a,b   Pandha, Hardev ^a,b  

^a Postgraduate Medical School   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cryotherapy; IL 6; Necrosis; TRAIL

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CRYOTHERAPY; FREEZE THAWING; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; THERAPY EFFECT;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; CRYOTHERAPY; HUMANS; MALE; NECROSIS; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 69049083268     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2009.07.008     Document Type: Article

References (28)

1. J.G. Baust, A.A. Gage, D. Clarke, J.M. Baust, R. Van Buskirk, Cryosurgery - a putative approach to molecular-based optimization, Cryobiology 48 (2004) 190-204.
2. A.H. Boulares, A.G. Yakovlev, V. Ivanova, B.A. Stoica, G. Wang, S. Iyer, et al., Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells, J. Biol. Chem. 274 (1999) 22932-22940.
3. Bischof J.C., Smith D., Pazhayannur P.V., et al. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level. Cryobiology 34 (1997) 42-69
4. Cancer Research UK, Prostate cancer incidence and statistics, Cancer Research UK, 2007.
5. X. Chen, H. Thakkar, F. Tyan, S. Gim, H. Robinson, C. Lee, S.K. Pandey, C. Nwokorie, N. Onwudiwe, R.K. Srivastava, Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer, Oncogene 20 (2001) 6073-6083.
6. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22 (1984) 27-55
7. Clarke D.M., Baust J.M., Van Buskirk R.G., and Baust J.G. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology 49 (2004) 45-61
8. Clarke D.M., Robilotto A.T., VanBuskirk R.G., Baust J.G., Gage A.A., and Baust J.M. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 10 (2007) 175-184
9. Cohen J.K., Miller Jr. R.J., Ahmed S., Lotz M.J., and Baust J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 71 (2008) 515-518
10. R.N. DuBois, J. Shao, M. Tsujii, H. Sheng, R.D. Beauchamp, G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2, Cancer Res. 56 (1996) 733-737.
11. Flocks R.H., Nelson C.M., and Boatman D.L. Perineal cryosurgery for prostatic carcinoma. J. Urol. 108 (1972) 933-935
12. R. Goel, D. Swanlund, J. Coad, G.F. Paciotti, J.C. Bischof, TNF-alpha-based accentuation in cryoinjury - dose, delivery, and response, Mol. Cancer Ther. 6 (2007) 2039-2047.
13. Gonder M.J., Soanes W.A., and Smith V. Experimental prostate cryosurgery. Invest. Urol. 1 (1964) 610-619
14. Han K.R., Cohen J.K., Miller R.J., Pantuck A.J., Freitas D.G., Cuevas C.A., et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J. Urol. 170 (2003) 1126-1130
15. Hesry V., Piquet-Pellorce C., Travert M., Donaghy L., Jegou B., Patard J.J., et al. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression DR5 and caspase 8 are key players. Prostate 66 (2006) 987-995
16. Ismail M., Hardev P., and Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: current status and future perspectives. Therapy 5 (2008) 37-45
17. Klossner D.P., Robilotto A.T., Clarke D.M., VanBuskirk R.G., Baust J.M., Gage A.A., et al. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology 55 (2007) 189-199
18. S. Kobayashi, N.W. Werneburg, S.F. Bronk, S.H. Kaufmann, G.J. Gores, Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells, Gastroenterology 128(2005) 2054-2065.
19. Larson T.R., Rrobertson D.W., Corica A., and Bostwick D.G. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 55 (2000) 547-552
20. Z.M. Liu, G.G. Chen, E.K. Ng, W.K. Leung, J.J. Sung, S.C. Chung, Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells, Oncogene 23 (2004) 503-513.
21. W. Lou, Z. Ni, K. Dyer, D.J. Tweardy, A.C. Gao, Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway, Prostate 42 (2000) 239-242.
22. A. Munshi, G. Pappas, T. Honda, T.J. McDonnell, A. Younes, Y. Li, R.E. Meyn, TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2, Oncogene 20(2001) 3757-3765.
23. Nesterov A., Lu X., Johnson M., Miller G.J., Ivashchenko Y., and Kraft A.S. Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J. Biol. Chem. 276 (2001) 10767-10774
24. Onik G.M., Cohen J.K., Reyes G.D., Rubinsky B., Chang Z., and Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72 (1993) 1291-1299
25. Schwarze S.R., DePrimo S.E., Grabert L.M., Fu V.X., Brooks J.D., and Jarrard D.F. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277 (2002) 14877-14883
26. Tenniswood M., and Yu Lee C. On TRAIL of cell death pathways in prostate cancer. Cancer Biol. Therapy 3 (2004) 769-771
27. N.A. Timchenko, T.E. Harris, M. Wilde, T.A. Bilyeu, B.L. Burgess-Beusse, M.J. Finegold, et al., CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice, Mol. Cell. Biol. 17 (1997) 7353-7361.
28. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682